6.04
price up icon0.33%   0.02
 
loading
전일 마감가:
$6.02
열려 있는:
$6.2
하루 거래량:
179.57K
Relative Volume:
1.40
시가총액:
$119.02M
수익:
$52.55M
순이익/손실:
$-23.69M
주가수익비율:
-6.4255
EPS:
-0.94
순현금흐름:
$-15.29M
1주 성능:
-9.17%
1개월 성능:
+49.88%
6개월 성능:
+145.53%
1년 성능:
+331.43%
1일 변동 폭
Value
$5.58
$6.25
1주일 범위
Value
$5.58
$7.00
52주 변동 폭
Value
$1.35
$7.00

Exagen Inc Stock (XGN) Company Profile

Name
명칭
Exagen Inc
Name
전화
(760) 560-1501
Name
주소
1261 LIBERTY WAY, VISTA, CA
Name
직원
209
Name
트위터
@ExagenInc
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
XGN's Discussions on Twitter

XGN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
XGN
Exagen Inc
6.04 119.02M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
423.18 159.05B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
198.92 140.21B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
478.72 35.17B 3.90B 887.87M 798.08M 10.67
Diagnostics & Research icon
A
Agilent Technologies Inc
109.11 30.47B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
153.78 26.47B 15.41B 1.37B 2.11B 7.50

Exagen Inc Stock (XGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-08-05 다운그레이드 KeyBanc Capital Markets Overweight → Sector Weight
2021-10-15 재개 Cowen Outperform
2021-04-15 개시 Canaccord Genuity Buy
2020-11-10 개시 KeyBanc Capital Markets Overweight
2020-10-08 개시 BTIG Research Buy
2020-06-02 재개 Cantor Fitzgerald Overweight
2019-10-14 개시 Cantor Fitzgerald Overweight
2019-10-14 개시 Cowen Outperform
2019-10-14 개시 William Blair Outperform
모두보기

Exagen Inc 주식(XGN)의 최신 뉴스

pulisher
10:23 AM

Earnings call transcript: Exagen Inc. Q1 2025 revenue beats forecasts, stock dips - Investing.com Australia

10:23 AM
pulisher
09:43 AM

Exagen Inc reports results for the quarter ended March 31Earnings Summary - TradingView

09:43 AM
pulisher
09:33 AM

EXAGEN INC. SEC 10-Q Report - TradingView

09:33 AM
pulisher
08:31 AM

Exagen Inc (XGN) Q1 2025 Earnings: Revenue Surpasses Estimates at $15.5M, EPS Matches Expectations at -$0.20 - GuruFocus

08:31 AM
pulisher
08:25 AM

Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in Average Selling Price and Testing Volume | XGN Stock News - GuruFocus

08:25 AM
pulisher
08:18 AM

XGN Projects Revenue Growth and Positive EBITDA by 2025 | XGN Stock News - GuruFocus

08:18 AM
pulisher
08:05 AM

Exagen Inc. Reports Record Q1 2025 Revenue - TradingView

08:05 AM
pulisher
08:00 AM

Exagen Q1 Earnings: Record $15.5M Revenue as New Lupus Test Launch Sparks Growth Path to Profitability - Stock Titan

08:00 AM
pulisher
May 03, 2025

Geode Capital Management LLC Grows Holdings in Exagen Inc. (NASDAQ:XGN) - Defense World

May 03, 2025
pulisher
May 02, 2025

Exagen Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView

May 02, 2025
pulisher
May 02, 2025

Exagen Inc (XGN) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus

May 02, 2025
pulisher
May 01, 2025

Exagen announces senior secured credit facility - MSN

May 01, 2025
pulisher
Apr 28, 2025

Exagen (XGN) Secures $75 Million Credit Facility to Enhance Fina - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Exagen secures $75 million credit facility with Perceptive Advisors By Investing.com - Investing.com South Africa

Apr 28, 2025
pulisher
Apr 28, 2025

Exagen Secures $75 Million Credit Agreement - TipRanks

Apr 28, 2025
pulisher
Apr 28, 2025

Exagen Enters up to $75 Million Credit Facility - marketscreener.com

Apr 28, 2025
pulisher
Apr 28, 2025

Exagen secures $75 million credit facility with Perceptive Advisors - Investing.com India

Apr 28, 2025
pulisher
Apr 28, 2025

Exagen Inc. Announces Senior Secured Credit Facility with Percep - GuruFocus

Apr 28, 2025
pulisher
Apr 28, 2025

Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors - GlobeNewswire

Apr 28, 2025
pulisher
Apr 26, 2025

Exagen stock soars to 52-week high, hits $6.23 amid robust gains - Investing.com Australia

Apr 26, 2025
pulisher
Apr 26, 2025

Exagen: Buy An Undervalued Diagnostics Developer That Is On Path To Profitability (XGN) - Seeking Alpha

Apr 26, 2025
pulisher
Apr 25, 2025

Exagen stock soars to 52-week high, hits $6.23 amid robust gains By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

With Exagen Up 30%, Insider Buyers Count Their Returns - simplywall.st

Apr 25, 2025
pulisher
Apr 25, 2025

Institutional investors control 30% of Exagen Inc. (NASDAQ:XGN) and were rewarded last week after stock increased 30% - Yahoo Finance

Apr 25, 2025
pulisher
Apr 21, 2025

Exagen Inc. to Release Q1 2025 Financial Results on May 5, 2025, with Conference Call Details - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025 - The Manila Times

Apr 21, 2025
pulisher
Apr 21, 2025

Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025 | XGN Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 15, 2025

Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World

Apr 15, 2025
pulisher
Apr 12, 2025

Exagen Inc. (NASDAQ:XGN) Shares Sold by Prudential Financial Inc. - Defense World

Apr 12, 2025
pulisher
Apr 03, 2025

Corient Private Wealth LLC Invests $45,000 in Exagen Inc. (NASDAQ:XGN) - Defense World

Apr 03, 2025
pulisher
Apr 03, 2025

There's No Escaping Exagen Inc.'s (NASDAQ:XGN) Muted Revenues Despite A 45% Share Price Rise - simplywall.st

Apr 03, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Purchases New Position in Exagen Inc. (NASDAQ:XGN) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

Short Interest in Exagen Inc. (NASDAQ:XGN) Drops By 23.5% - The AM Reporter

Mar 31, 2025
pulisher
Mar 29, 2025

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 29, 2025
pulisher
Mar 28, 2025

Exagen Inc. sees $1.16 million stock sale by NMSIC Co-Investment Fund By Investing.com - Investing.com Philippines

Mar 28, 2025
pulisher
Mar 27, 2025

Major Shareholder Sells Off Huge Chunk of Exagen Stock! - TipRanks

Mar 27, 2025
pulisher
Mar 15, 2025

FY2025 EPS Estimates for Exagen Lowered by Cantor Fitzgerald - Defense World

Mar 15, 2025
pulisher
Mar 15, 2025

Equities Analysts Offer Predictions for Exagen Q1 Earnings - Defense World

Mar 15, 2025
pulisher
Mar 14, 2025

Exagen Inc. (NASDAQ:XGN) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo

Mar 14, 2025
pulisher
Mar 14, 2025

William Blair Reaffirms “Outperform” Rating for Exagen (NASDAQ:XGN) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

FY2026 Earnings Forecast for Exagen Issued By William Blair - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

FY2024 EPS Estimates for Exagen Raised by Cantor Fitzgerald - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Exagen Inc. Reports Record Revenue and Positive Outlook - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Exagen Inc. (NASDAQ:XGN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Exagen Full Year 2024 Earnings: EPS Beats Expectations - Yahoo

Mar 12, 2025
pulisher
Mar 12, 2025

Exagen’s Positive Outlook: Buy Rating Backed by Strong Performance and Growth Potential - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Exagen Inc (XGN) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - Yahoo

Mar 12, 2025
pulisher
Mar 12, 2025

Exagen Inc. Reports Record 2024 Financial Results - TipRanks

Mar 12, 2025
pulisher
Mar 11, 2025

BTIG maintains Buy rating, $5 target on Exagen stock - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

BTIG maintains Buy rating, $5 target on Exagen stock By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

Earnings call transcript: Exagen Inc Q4 2024 sees revenue growth and stock rise - Investing.com

Mar 11, 2025

Exagen Inc (XGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Exagen Inc 주식 (XGN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
NMSIC Co-Investment Fund, L.P.
10% Owner
Nov 20 '24
Sale
3.30
200,000
660,040
2,108,958
Black Jeffrey G.
Chief Financial Officer
Nov 15 '24
Buy
2.98
22,298
66,448
274,492
ABALLI JOHN
President and CEO
Nov 14 '24
Buy
2.81
24,305
68,297
689,799
diagnostics_research LH
$248.03
price up icon 0.15%
diagnostics_research DGX
$178.49
price up icon 0.33%
diagnostics_research WAT
$352.40
price up icon 0.43%
$158.28
price up icon 1.01%
diagnostics_research MTD
$1,101.16
price up icon 0.07%
diagnostics_research IQV
$153.92
price up icon 0.31%
자본화:     |  볼륨(24시간):